Literature DB >> 6682682

Skin conductance and subjective assessments associated with the odour of 5-alpha-androstan-3-one.

C Van Toller, M Kirk-Smith, N Wood, J Lombard, G H Dodd.   

Abstract

Two experiments are reported using the odours of 5-alpha-androstan-3-one (androstanone) and, a control odour, aurantiol. Various measures of skin conductance (SC) were recorded and analysed and subjects also rated the odours using analogue scales. The first experiment involved comparisons between subjects who perceive the androstanone odour as pleasant and subjects who perceive it as unpleasant. A number of differences were shown between the two groups and also between androstanone and aurantiol. The results are interpreted as demonstrating the influence of cognitive factors that are found between male and female responses and also between the responses of the 'pleasant' and 'unpleasant' groups. The second experiment examined the SC response of subjects who displayed specific anosmia to the odour of androstanone. The results suggest that the concept of specific anosmia requires modification.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6682682     DOI: 10.1016/0301-0511(83)90056-x

Source DB:  PubMed          Journal:  Biol Psychol        ISSN: 0301-0511            Impact factor:   3.251


  4 in total

1.  [Specific anosmia as a principle of olfactory perception].

Authors:  I Croy; S Olgun; L Mueller; A Schmidt; M Muench; G Gisselmann; H Hatt; T Hummel
Journal:  HNO       Date:  2016-05       Impact factor: 1.284

2.  Olfactory sexual inhibition and the westermarck effect.

Authors:  M A Schneider; L Hendrix
Journal:  Hum Nat       Date:  2000-03

3.  Evidence for peripheral plasticity in human odour response.

Authors:  Liwei Wang; Lixin Chen; Tim Jacob
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

4.  Subliminally perceived odours modulate female intrasexual competition: an eye movement study.

Authors:  Valentina Parma; Roberto Tirindelli; Angelo Bisazza; Stefano Massaccesi; Umberto Castiello
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.